December 7, 2016
Neovac’s Lupus vaccine on USFDA’s fast track
The U.S. Food and Drug Administration (FDA) has granted “Fast Track” status to French biopharmaceutical company Neovacs’s IFNalpha Kinoid in…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
December 2, 2016
Amryt loans from EIB for skin disorder gel aimed for $1.5 billion market
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
November 10, 2016
BD and JDRF join forces to fight type 1 diabetes
BD has announced a new research collaboration supported by JDRF, the global organization funding…
November 9, 2016
Bristol-Myers, Infinity Pharmaceuticals join forces to test drug in advanced solid tumors
ristol-Myers Squibb Company and Infinity Pharmaceuticals have announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo …
November 8, 2016
BD launches first syringe designed for use with Humulin R U-500 insulin
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
November 8, 2016
After $195 million in talc verdicts, J&J strives to change court
After a $67.5 million jury verdict against Johnson & Johnson…
November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
November 7, 2016
Vertex's Phase 3 cystic fibrosis drug study shows improvement
Vertex Pharmaceuticals Incorporated today announced the results of a Phase 3 study of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis…
November 7, 2016
Neovacs enroles first U.S. patient in its Phase IIb study of IFNalpha Kinoid in lupus.
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
November 7, 2016
Amryt gets FDA's designation for orphan drug to treat acromegaly
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…